Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.54 |
| ▸ | HPGD | P15428 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | ESR1 | P03372 | 1/20 | 0.53 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.53 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.53 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.53 |
| ▸ | GGT1 | P19440 | 1/20 | 0.53 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.53 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.53 |
| ▸ | BLM | P54132 | 1/20 | 0.53 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.51 |
| ▸ | LMNA | P02545 | 5/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1004350 | 0.91 | KMT2A (0.59) | HSD17B10KDM4EHPGDALDH1A1TSHR | |
| SCHEMBL360782 | 0.85 | KDM4E (0.68) | HSD17B10KDM4EHPGDALDH1A1TSHR | |
| SCHEMBL4392121 | 0.84 | HSD17B10 (0.62) | HSD17B10KDM4EHPGDALDH1A1TSHR | |
| SCHEMBL1282392 | 0.83 | SLC6A3 (0.66) | HSD17B10KDM4EHPGDALDH1A1TSHR | |
| SCHEMBL1282370 | 0.82 | HSD17B10 (0.51) | HSD17B10KDM4EHPGDALDH1A1TSHR | |
| SCHEMBL1913832 | 0.82 | HSD17B10 (0.53) | HSD17B10KDM4EHPGDALDH1A1TSHR | |
| SCHEMBL1282647 | 0.81 | HSD17B10 (0.64) | HSD17B10KDM4EHPGDALDH1A1TSHR | |
| SCHEMBL13920473 | 0.81 | KDM4E (0.73) | HSD17B10KDM4EHPGDALDH1A1TSHR | |
| SCHEMBL29361191 | 0.81 | KDM4E (0.60) | HSD17B10KDM4EHPGDALDH1A1TSHR | |
| SCHEMBL26806952 | 0.81 | KDM4E (0.60) | HSD17B10KDM4EHPGDALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-100349952-C | Method for producing polycarbonate | GEN ELECTRIC (US) | 2007-11-21 | — | — | CN | disclosed |
| CN-1610715-A | Process for the production of polycarbonate | GEN ELECTRIC (US) | 2005-04-27 | — | — | CN | disclosed |
| EP-1427770-B1 | PROCESS FOR THE PRODUCTION OF POLYCARBONATE | GEN ELECTRIC (US) | 2005-01-19 | — | — | EP | disclosed |
| EP-1427770-A1 | PROCESS FOR THE PRODUCTION OF POLYCARBONATE | GENERAL ELECTRIC COMPANY (US) | 2004-06-16 | — | — | EP | disclosed |
| US-20030120025-A1 | Process for the production of polycarbonate | GENERAL ELECTRIC COMPANY | 2003-06-26 | — | — | US | disclosed |
| WO-2003022905-A1 | PROCESS FOR THE PRODUCTION OF POLYCARBONATE | GENERAL ELECTRIC COMPANY (US) | 2003-03-20 | — | — | WO | disclosed |
| US-6525163-B1 | Reducing static charge, improving heat aging, and lowering water absorption by increasing endcap levels | GENERAL ELECTRIC COMPANY | 2003-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030120025-A1 | Process for the production of polycarbonate | RNGTT, CAPG, RPL30 | HSD17B10 2598/4885KDM4E 394/4885HPGD 4508/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.